CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease.

MLA

Ma, Christopher, et al. “CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease.” Gastroenterology, vol. 163, no. 4, Oct. 2022, pp. 950–64. EBSCOhost, https://doi.org/10.1053/j.gastro.2022.06.068.

APA

Ma, C., Hanzel, J., Panaccione, R., Sandborn, W. J., D’Haens, G. R., Ahuja, V., Atreya, R., Bernstein, C. N., Bossuyt, P., Bressler, B., Bryant, R. V., Cohen, B., Colombel, J.-F., Danese, S., Dignass, A., Dubinsky, M. C., Fleshner, P. R., Gearry, R. B., Hanauer, S. B., … Jairath, V. (2022). CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease. Gastroenterology, 163(4), 950–964. https://doi.org/10.1053/j.gastro.2022.06.068

Chicago

Ma, Christopher, Jurij Hanzel, Remo Panaccione, William J Sandborn, Geert R D’Haens, Vineet Ahuja, Raja Atreya, et al. 2022. “CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease.” Gastroenterology 163 (4): 950–64. doi:10.1053/j.gastro.2022.06.068.